Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 80425-0419

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 80425-0419). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium Dr 20mg #30 (Esomeprazole Magnesium Dr 20mg 80425 0419 01)

Label for Esomeprazole Magnesium delayed-release capsules, 20 mg strength, pack of 30, by Advanced Rx of Tennessee, LLC. Includes storage instructions, comparisons to Nexium, NDC 80425-0419-01, and expiration date of 5/31/2025. Contains a barcode and pharmacy information for Camber Pharmace.*

FDA Label Image

Esomeprazole Magnesium Dr 20mg #60 (Esomeprazole Magnesium Dr 20mg 80425 0419 02)

Esomeprazole Magnesium 20 mg delayed-release capsules label showing the product name, strength, dosage form, and a quantity of 60 capsules. The label includes storage instructions, NDC 80425-0419-02, comparison to Nexium, lot number, expiration date May 31, 2025, and is labeled Rx only. Advanced Rx of Tennessee, LLC is the packer, and Camber Pharmace is noted along with a serial number.*

FDA Label Image

Esomeprazole Magnesium Dr 20mg #90 (Esomeprazole Magnesium Dr 20mg 80425 0419 03)

Label for Esomeprazole Magnesium, 20 mg delayed-release capsules from Advanced Rx of Tennessee, LLC. The label includes NDC 80425-0419-03, lot number, expiration date (5/31/2025), and storage instructions (20°-25°C). It also references Nexium and provides barcodes for identification.*

FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

Chemical structure diagram of Esomeprazole Magnesium showing its molecular composition including magnesium ion complexed with esomeprazole molecules and associated water molecules.*

FDA Label Image

Figure-2 (Figure 2)

A line graph depicting the percent maintained over a six-month period for Esomeprazole Magnesium Delayed-Release Capsules at doses of 40 mg, 20 mg, and 10 mg, compared to placebo. The x-axis represents the months, and the y-axis shows the percent maintained, with data points and lines illustrating the comparative maintenance rates of the four groups.*

FDA Label Image

Figure-3 (Figure 3)

A line graph showing the percentage maintained over a 6-month period for esomeprazole magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg doses compared to placebo. The Y-axis represents percent maintained from 0 to 100, and the X-axis shows months from 0 to 6. Different line styles distinguish the four groups, with 40 mg generally maintaining the highest percentage.*

FDA Label Image

Figure-4 (Figure 4)

Line chart comparing the percentage of patients symptom-free over 28 days between patients taking Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The x-axis represents diary days from 0 to 28, and the y-axis represents the percent of patients symptom-free from 0% to 100%. The chart shows that symptom-free rates increase over time for both dosages compared to placebo.*

FDA Label Image

Figure-5 (Figure 5)

A line graph showing the percent of patients symptom-free over 28 diary days. It compares Esomeprazole Magnesium Delayed-Release Capsules at 40 mg and 20 mg doses with a placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.